{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T12:09:52Z","timestamp":1768824592822,"version":"3.49.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2013,6,30]],"date-time":"2013-06-30T00:00:00Z","timestamp":1372550400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CNS Drugs"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1007\/s40263-013-0085-7","type":"journal-article","created":{"date-parts":[[2013,6,29]],"date-time":"2013-06-29T10:50:48Z","timestamp":1372503048000},"page":"731-741","source":"Crossref","is-referenced-by-count":17,"title":["Efficacy and Tolerability of Perospirone in Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials"],"prefix":"10.1007","volume":"27","author":[{"given":"Taro","family":"Kishi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nakao","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,6,30]]},"reference":[{"issue":"4","key":"85_CR1","doi-asserted-by":"crossref","first-page":"329","DOI":"10.2165\/00023210-200115040-00006","volume":"15","author":"S Onrust","year":"2001","unstructured":"Onrust S, McClellan K. Perospirone. CNS Drugs. 2001;15(4):329\u201337.","journal-title":"CNS Drugs"},{"issue":"1","key":"85_CR2","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/sj.mp.4001556","volume":"10","author":"S Miyamoto","year":"2005","unstructured":"Miyamoto S, Duncan GE, Marx CE, Lieberman JA. Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs. Mol Psychiatry. 2005;10(1):79\u2013104.","journal-title":"Mol Psychiatry"},{"key":"85_CR3","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jpsychires.2012.10.011","volume":"47","author":"T Kishi","year":"2013","unstructured":"Kishi T, Matsuda Y, Nakamura H, Iwata N. Blonanserin for schizophrenia: systematic review and meta-analysis of double-blind, randomized, controlled trials. J Psychiatr Res. 2013;47:149\u201354.","journal-title":"J Psychiatr Res"},{"key":"85_CR4","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.pnpbp.2012.09.010","volume":"40","author":"Y Takekita","year":"2013","unstructured":"Takekita Y, Kato M, Wakeno M, Sakai S, Suwa A, Nishida K, et al. A 12-week randomized, open-label study of perospirone versus aripiprazole in the treatment of Japanese schizophrenia patients. Prog Neuropsychopharmacol Biol Psychiatry. 2013;40:110\u20134.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"85_CR5","first-page":"207","volume":"24","author":"Y Kudo","year":"1997","unstructured":"Kudo Y, Nakajima T, Saito M, Sakai T, Otsuki S, Yamasaki S, et al. Clinical evaluation of a serotonin-2 and dopamine-2 receptor antagonist (SDA), perospirone HCI on schizophrenia: a comparative double-blind study with mosapramine HCI. Clin Eval. 1997;24:207\u201348.","journal-title":"Clin Eval"},{"key":"85_CR6","first-page":"159","volume":"24","author":"M Murasaki","year":"1997","unstructured":"Murasaki M, Koyama T, Yukiteru M, Gohei Y, Kamijima K, Toru M, et al. Clinical evaluation of a new antipsychotic, perospirone HCI, on schizophrenia: a comparative double-blind study with haloperidol. Clin Eval. 1997;24:159\u2013205.","journal-title":"Clin Eval"},{"key":"85_CR7","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.4088\/JCP.v65n1114","volume":"65","author":"H Yamashita","year":"2004","unstructured":"Yamashita H, Mori K, Nagao M, Okamoto Y, Morinobu S, Yamawaki S. Effects of changing from typical to atypical antipsychotic drugs on subjective sleep quality in patients with schizophrenia in a Japanese population. J Clin Psychiatry. 2004;65:1525\u201330.","journal-title":"J Clin Psychiatry"},{"key":"85_CR8","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1440-1819.2009.01947.x","volume":"63","author":"G Okugawa","year":"2009","unstructured":"Okugawa G, Kato M, Wakeno M, Koh J, Morikawa M, Matsumoto N, et al. Randomized clinical comparison of perospirone and risperidone in patients with schizophrenia: Kansai Psychiatric Multicenter Study. Psychiatry Clin Neurosci. 2009;63:322\u20138.","journal-title":"Psychiatry Clin Neurosci"},{"issue":"2","key":"85_CR9","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","volume":"13","author":"SR Kay","year":"1987","unstructured":"Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13(2):261\u201376.","journal-title":"Schizophr Bull"},{"issue":"3","key":"85_CR10","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1037\/1082-989X.8.3.243","volume":"8","author":"LD Cohn","year":"2003","unstructured":"Cohn LD, Becker BJ. How meta-analysis increases statistical power. Psychol Methods. 2003;8(3):243\u201353.","journal-title":"Psychol Methods"},{"issue":"15","key":"85_CR11","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","volume":"283","author":"DF Stroup","year":"2000","unstructured":"Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283(15):2008\u201312.","journal-title":"JAMA"},{"issue":"2\u20133","key":"85_CR12","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0920-9964(01)00314-0","volume":"57","author":"T Inada","year":"2002","unstructured":"Inada T, Yagi G, Miura S. Extrapyramidal symptom profiles in Japanese patients with schizophrenia treated with olanzapine or haloperidol. Schizophr Res. 2002;57(2\u20133):227\u201338.","journal-title":"Schizophr Res"},{"issue":"2","key":"85_CR13","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2302\/kjm.45.95","volume":"45","author":"T Inada","year":"1996","unstructured":"Inada T, Yagi G. Current topics in neuroleptic-induced extrapyramidal symptoms in Japan. Keio J Med. 1996;45(2):95\u20139.","journal-title":"Keio J Med"},{"issue":"3","key":"85_CR14","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177\u201388.","journal-title":"Control Clin Trials"},{"issue":"7414","key":"85_CR15","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557\u201360.","journal-title":"BMJ"},{"issue":"9657","key":"85_CR16","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(08)61764-X","volume":"373","author":"S Leucht","year":"2009","unstructured":"Leucht S, Corves C, Arbter D, Engel RR, Li C, Davis JM. Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis. Lancet. 2009;373(9657):31\u201341.","journal-title":"Lancet"},{"issue":"2","key":"85_CR17","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1176\/appi.ajp.2008.08030368","volume":"166","author":"S Leucht","year":"2009","unstructured":"Leucht S, Komossa K, Rummel-Kluge C, Corves C, Hunger H, Schmid F, et al. A meta-analysis of head-to-head comparisons of second-generation antipsychotics in the treatment of schizophrenia. Am J Psychiatry. 2009;166(2):152\u201363.","journal-title":"Am J Psychiatry"},{"issue":"1","key":"85_CR18","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/schbul\/sbq042","volume":"38","author":"C Rummel-Kluge","year":"2012","unstructured":"Rummel-Kluge C, Komossa K, Schwarz S, Hunger H, Schmid F, Kissling W, et al. Second-generation antipsychotic drugs and extrapyramidal side effects: a systematic review and meta-analysis of head-to-head comparisons. Schizophr Bull. 2012;38(1):167\u201377.","journal-title":"Schizophr Bull"},{"issue":"7","key":"85_CR19","first-page":"1443","volume":"9","author":"A Inagaki","year":"2006","unstructured":"Inagaki A, Inada T. Equivalent doses of psychotropic drugs. Jpn J Clin Psychopharmacol. 2006;9(7):1443\u20137.","journal-title":"Jpn J Clin Psychopharmacol"},{"issue":"16","key":"85_CR20","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1001\/jama.2009.1549","volume":"302","author":"CU Correll","year":"2009","unstructured":"Correll CU, Manu P, Olshanskiy V, Napolitano B, Kane JM, Malhotra AK. Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents. JAMA. 2009;302(16):1765\u201373.","journal-title":"JAMA"}],"container-title":["CNS Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-013-0085-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40263-013-0085-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-013-0085-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T19:41:18Z","timestamp":1559504478000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40263-013-0085-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,30]]},"references-count":20,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["85"],"URL":"https:\/\/doi.org\/10.1007\/s40263-013-0085-7","relation":{},"ISSN":["1172-7047","1179-1934"],"issn-type":[{"value":"1172-7047","type":"print"},{"value":"1179-1934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,30]]}}}